Skip to main content
Caplight Logo









Ossium Health

Ossium Health

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://ossiumhealth.com

Last Round

Grant

Sep 30, 2024

Total Funding Raised

$151.71M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ossium Health operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in September 2024.

Ossium Health is a biotechnology company that develops stem cell-based therapies using a proprietary deceased donor bone marrow banking platform to treat patients with hematologic, immune, and orthopedic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ossium Health Comparables

Compare Ossium Health with similar companies based on industry and business-model similarity.

Ossium Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pinnacle Transplant Technologies
75%
Gamida Cell Ltd.
74%
AlloSource
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ossium Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 30, 2024
Series CJul 25, 2023
GrantApr 28, 2023
Series BMar 18, 2021
Series AMay 24, 2018
Grant
Sep 1, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Erik Woods

Co Founder, Executive Vice President And Chief Science Officer

Founding Team

Kevin Caldwell

CEO & Co-Founder

Founding Team

For institutional investors. Book with your work email.

Ossium Health Investors

Notable investors and investment history

Book a demo to see all 13 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 74% MoM, from 3.5K to 6.2K.

  • Mar 3, 2026

    Named to Forbes' list of America's Best Startup Employers for the second time.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventNov 5, 2026

    Ossium Health, Inc. presents four abstracts at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition in Louisiana from Dec 12th-15th '26.

  • receives_awardOct 27, 2026

    Ossium Health, Inc. CEO Kevin Caldwell wins the 2026 Biocom Catalyst Award from Biocom at the 2026 Catalyst Awards in California on Oct 27th '26 for building Ossium Health, Inc. into the first bone marrow bank of its kind.

  • attends_eventOct 14, 2026

    Ossium Health, Inc. attends the 2026 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting in Georgia from Oct 17th to Oct 19th '26, where its abstract is selected as a Top Poster and featured on Oct 18th '26.

  • recognized_asOct 14, 2026

    Ossium Health, Inc. has its abstract selected as a Top Poster by the Association for the Advancement of Blood & Biotherapies at the 2026 AABB Annual Meeting in Georgia, where it is featured in the curated Top Posters Tour on Oct 18th '26.

  • recognized_asSep 22, 2026

    Ossium Health, Inc. participates as a Bronze Partner in the World Marrow Donor Association's World Marrow Donor Day observance on Sep 22nd '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Ossium Health Filings

Explore SEC and related filing metadata, where available.

Ossium Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ossium Health's valuation, stock price, and market status.

Is Ossium Health a public or private company?

Ossium Health is a private company.

What is the current stock price of Ossium Health?

Ossium Health is a private company, so its shares have no public market price. Caplight tracks Ossium Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ossium Health worth (valuation)?

Valuation information for Ossium Health is not publicly available.

Can I buy Ossium Health stock?

Ossium Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ossium Health's last funding round?

Ossium Health's most recent funding round was Grant on September 30, 2024.

Who are the main investors in Ossium Health?

Key investors in Ossium Health include NIH RADx, Public Health Emergency Medical Countermeasures Enterprise, General Catalyst, California Institute for Regenerative Medicine, First Round Capital.

Will Ossium Health IPO soon?

No public IPO plans have been announced for Ossium Health.

How can I track Ossium Health secondary market activity?

Caplight tracks bids, offers, and trades in Ossium Health's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range88
Year Founded2016
Last FundingSep 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?